{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:54:30Z","timestamp":1790618070020,"version":"4.1.0"},"reference-count":81,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T00:00:00Z","timestamp":1534982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0202770","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T13:50:41Z","timestamp":1535032241000},"page":"e0202770","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":49,"title":["Charting the onset of Parkinson-like motor and non-motor symptoms in nonhuman primate model of Parkinson\u2019s disease"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8664-7638","authenticated-orcid":true,"given":"Gourav R.","family":"Choudhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0243-8909","authenticated-orcid":true,"given":"Marcel M.","family":"Daadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,8,23]]},"reference":[{"key":"ref1","article-title":"Disease modification in Parkinson's Disease: Current approaches, challenges, and future considerations","author":"AE Lang","year":"2018","journal-title":"Mov Disord"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","article-title":"Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease","volume":"164","author":"S Duty","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1073\/pnas.042497999","article-title":"Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans","volume":"99","author":"R Nass","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1074\/jbc.M504860200","article-title":"Familial Parkinson mutant alpha-synuclein causes dopamine neuron dysfunction in transgenic Caenorhabditis elegans","volume":"281","author":"T Kuwahara","year":"2006","journal-title":"J Biol Chem"},{"issue":"29","key":"ref5","doi-asserted-by":"crossref","first-page":"9210","DOI":"10.1523\/JNEUROSCI.2281-09.2009","article-title":"LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans","volume":"29","author":"S Saha","year":"2009","journal-title":"J Neurosci"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bbrc.2007.04.156","article-title":"Loss of LRRK2\/PARK8 induces degeneration of dopaminergic neurons in Drosophila","volume":"358","author":"SB Lee","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"6776","key":"ref7","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/35006074","article-title":"A Drosophila model of Parkinson's disease","volume":"404","author":"MB Feany","year":"2000","journal-title":"Nature"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1460-9568.2010.07091.x","article-title":"Impaired dopaminergic neuron development and locomotor function in zebrafish with loss of pink1 function","volume":"31","author":"Y Xi","year":"2010","journal-title":"Eur J Neurosci"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1111\/j.1471-4159.2006.04291.x","article-title":"p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson's disease","volume":"100","author":"S Bretaud","year":"2007","journal-title":"J Neurochem"},{"issue":"Pt 6","key":"ref10","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/brain\/awp108","article-title":"Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio rerio)","volume":"132","author":"L Flinn","year":"2009","journal-title":"Brain"},{"issue":"27","key":"ref11","doi-asserted-by":"crossref","first-page":"11441","DOI":"10.1073\/pnas.0702717104","article-title":"Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice","volume":"104","author":"T Kitada","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 2","key":"ref12","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.parkreldis.2008.04.004","article-title":"Strengths and limitations of genetic mouse models of Parkinson's disease","volume":"14","author":"MF Chesselet","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuron.2010.04.034","article-title":"Genetic animal models of Parkinson's disease","volume":"66","author":"TM Dawson","year":"2010","journal-title":"Neuron"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0014-4886(03)00246-2","article-title":"Primate models of Parkinson's disease","volume":"183","author":"TJ Collier","year":"2003","journal-title":"Exp Neurol"},{"key":"ref15","first-page":"600","article-title":"Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations","volume":"60","author":"LS Forno","year":"1993","journal-title":"Adv Neurol"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"a009308","DOI":"10.1101\/cshperspect.a009308","article-title":"Modeling Parkinson's disease in primates: The MPTP model","volume":"2","author":"G Porras","year":"2012","journal-title":"Cold Spring Harbor perspectives in medicine"},{"issue":"1\u20132","key":"ref17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0006-8993(90)90069-N","article-title":"Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys","volume":"519","author":"JS Schneider","year":"1990","journal-title":"Brain Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/bs.irn.2017.05.018","article-title":"Nonmotor Symptoms in Experimental Models of Parkinson's Disease","volume":"133","author":"N Titova","year":"2017","journal-title":"Int Rev Neurobiol"},{"issue":"Pt 3","key":"ref19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/brain\/113.3.617","article-title":"Cognitive and motor deficits in the acquisition of an object retrieval\/detour task in MPTP-treated monkeys","volume":"113","author":"JR Taylor","year":"1990","journal-title":"Brain"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1017\/S0317167100037859","article-title":"MPTP-induced parkinsonism in the monkey: neurochemical pathology, complications of treatment and pathophysiological mechanisms","volume":"14","author":"AR Crossman","year":"1987","journal-title":"Can J Neurol Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0079-6123(10)84007-5","article-title":"The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future","volume":"184","author":"SH Fox","year":"2010","journal-title":"Prog Brain Res"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"W Dauer","year":"2003","journal-title":"Neuron"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.nbd.2005.05.028","article-title":"Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates","volume":"20","author":"MG Purisai","year":"2005","journal-title":"Neurobiol Dis"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1073\/pnas.0409713102","article-title":"Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein","volume":"102","author":"F Fornai","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1471-4159.2000.740721.x","article-title":"Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP","volume":"74","author":"M Vila","year":"2000","journal-title":"J Neurochem"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nrneurol.2016.196","article-title":"Precision medicine for disease modification in Parkinson disease","volume":"13","author":"AJ Espay","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment","volume":"8","author":"KR Chaudhuri","year":"2009","journal-title":"Lancet Neurol"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mds.23795","article-title":"Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts","volume":"27","author":"KA Jellinger","year":"2012","journal-title":"Mov Disord"},{"issue":"s1","key":"ref29","first-page":"S73","article-title":"Neuropathological Staging of Brain Pathology in Sporadic Parkinson's disease: Separating the Wheat from the Chaff","volume":"7","author":"H Braak","year":"2017","journal-title":"J Parkinsons Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/bs.irn.2017.05.005","article-title":"Neuropathology of Nonmotor Symptoms of Parkinson's Disease","volume":"133","author":"KA Jellinger","year":"2017","journal-title":"Int Rev Neurobiol"},{"issue":"15","key":"ref31","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","article-title":"Parkinson's Disease","volume":"339","author":"AE Lang","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"ref32","first-page":"153","article-title":"Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway","volume":"14","author":"KA Jellinger","year":"1991","journal-title":"Mol Chem Neuropathol"},{"key":"ref33","first-page":"15","article-title":"Nigral and extranigral pathology in Parkinson's disease","volume":"46","author":"H Braak","year":"1995","journal-title":"J Neural Transm Suppl"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1124\/jpet.102.039743","article-title":"Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates","volume":"303","author":"MJ Hansard","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.expneurol.2005.10.022","article-title":"Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys","volume":"197","author":"KS Bankiewicz","year":"2006","journal-title":"Experimental Neurology"},{"key":"ref36","doi-asserted-by":"crossref","DOI":"10.1002\/0471140856.tx0108s18","article-title":"Preclinical models of Parkinson's disease","author":"KS Bankiewicz","year":"2004","journal-title":"Current protocols in toxicology"},{"key":"ref37","first-page":"153","article-title":"Recent developments in Parkinson's disease","volume":"2","author":"S Fahn","year":"1987"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"MM Hoehn","year":"1967","journal-title":"Neurology"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/STROKEAHA.115.012506","article-title":"Impaired Arm Function and Finger Dexterity in a Nonhuman Primate Model of Stroke: Motor and Cognitive Assessments","volume":"47","author":"CR McEntire","year":"2016","journal-title":"Stroke"},{"issue":"Suppl 3","key":"ref40","first-page":"2","article-title":"Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee","volume":"13","author":"G Deuschl","year":"1998","journal-title":"Mov Disord"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington- clinical, morphological and neurochemical correlations","volume":"20","author":"H Berheimer","year":"1973","journal-title":"Journal of Neurological Sciences"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"H Braak","year":"2003","journal-title":"Neurobiol Aging"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: diagnosis and management","volume":"5","author":"KR Chaudhuri","year":"2006","journal-title":"Lancet Neurol"},{"issue":"8","key":"ref44","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/01.WNL.0000158422.41380.82","article-title":"Cognitive status correlates with neuropathologic stage in Parkinson disease","volume":"64","author":"H Braak","year":"2005","journal-title":"Neurology"},{"issue":"9","key":"ref45","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1212\/01.WNL.0000091864.39702.1C","article-title":"Assessment of cognition in Parkinson's disease","volume":"61","author":"J Marinus","year":"2003","journal-title":"Neurology"},{"issue":"Pt 8","key":"ref46","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1093\/brain\/awm142","article-title":"Patterns of levodopa response in Parkinson's disease: a clinico-pathological study","volume":"130","author":"PA Kempster","year":"2007","journal-title":"Brain"},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1474-4422(04)00740-9","article-title":"Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough","volume":"3","author":"AE Lang","year":"2004","journal-title":"The Lancet Neurology"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.expneurol.2008.07.021","article-title":"Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: an in vivo 11C-raclopride PET study","volume":"214","author":"M Politis","year":"2008","journal-title":"Exp Neurol"},{"key":"ref49","article-title":"Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease","author":"GJ Masilamoni","year":"2017","journal-title":"Journal of neural transmission (Vienna, Austria: 1996)"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0306-4522(91)90080-8","article-title":"Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey","volume":"44","author":"C Pifl","year":"1991","journal-title":"Neuroscience"},{"issue":"3","key":"ref51","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.neuroimage.2011.03.012","article-title":"Progression of monoaminergic dysfunction in Parkinson's disease: a longitudinal 18F-dopa PET study","volume":"56","author":"N Pavese","year":"2011","journal-title":"Neuroimage"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.expneurol.2009.12.021","article-title":"In vivo assessment of brain monoamine systems in parkin gene carriers: a PET study","volume":"222","author":"N Pavese","year":"2010","journal-title":"Exp Neurol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nbd.2016.12.025","article-title":"Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys","volume":"100","author":"GJ Masilamoni","year":"2017","journal-title":"Neurobiol Dis"},{"issue":"4","key":"ref54","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ana.410200403","article-title":"Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys","volume":"20","author":"LS Forno","year":"1986","journal-title":"Ann Neurol"},{"issue":"5","key":"ref55","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.410320510","article-title":"Disease-specific patterns of locus coeruleus cell loss","volume":"32","author":"DC German","year":"1992","journal-title":"Ann Neurol"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0006-8993(90)90733-R","article-title":"Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease","volume":"510","author":"GM Halliday","year":"1990","journal-title":"Brain Res"},{"issue":"4","key":"ref57","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF00696560","article-title":"Parkinson's disease: distribution of Lewy bodies and monoamine neuron system","volume":"34","author":"E Ohama","year":"1976","journal-title":"Acta Neuropathol"},{"issue":"5","key":"ref58","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ana.410150503","article-title":"Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease","volume":"15","author":"I Nakano","year":"1984","journal-title":"Ann Neurol"},{"issue":"16","key":"ref59","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1073\/pnas.84.16.5976","article-title":"Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy","volume":"84","author":"EC Hirsch","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"ref60","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0028-3908(85)90070-X","article-title":"Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the macaque monkey","volume":"24","author":"AR Crossman","year":"1985","journal-title":"Neuropharmacology"},{"issue":"5","key":"ref61","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1460-9568.2004.03586.x","article-title":"Attention and executive function deficits in chronic low-dose MPTP-treated non-human primates","volume":"20","author":"E Decamp","year":"2004","journal-title":"Eur J Neurosci"},{"issue":"8","key":"ref62","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1212\/WNL.41.8.1298","article-title":"Occurrence of resting tremor in Parkinson's disease","volume":"41","author":"AH Rajput","year":"1991","journal-title":"Neurology"},{"issue":"2","key":"ref63","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1001\/archneur.1993.00540020018011","article-title":"A clinicopathologic study of 100 cases of Parkinson's disease","volume":"50","author":"AJ Hughes","year":"1993","journal-title":"Arch Neurol"},{"issue":"4","key":"ref64","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00002826-199108000-00008","article-title":"Effect of clonidine and atropine on rest tremor in the MPTP monkey model of parkinsonism","volume":"14","author":"B Gomez-Mancilla","year":"1991","journal-title":"Clin Neuropharmacol"},{"issue":"4975","key":"ref65","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1126\/science.2402638","article-title":"Reversal of experimental parkinsonism by lesions of the subthalamic nucleus","volume":"249","author":"H Bergman","year":"1990","journal-title":"Science"},{"issue":"14","key":"ref66","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"80","author":"RS Burns","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref67","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0006-8993(84)90777-7","article-title":"Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey","volume":"292","author":"JW Langston","year":"1984","journal-title":"Brain Res"},{"key":"ref68","first-page":"183","article-title":"Parkinson's Disease. Advances in Neurology","volume":"45","author":"P Jenner","year":"1986"},{"issue":"3","key":"ref69","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1353-8020(02)00115-3","article-title":"The contribution of the MPTP-treated primate model to the development of new treatment strategies for Parkinson's disease","volume":"9","author":"P Jenner","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"ref70","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/WNL.42.2.407","article-title":"Tremor in MPTP-induced parkinsonism","volume":"42","author":"JW Tetrud","year":"1992","journal-title":"Neurology"},{"issue":"Suppl 3","key":"ref71","first-page":"29","article-title":"Physiology of MPTP tremor","volume":"13","author":"H Bergman","year":"1998","journal-title":"Mov Disord"},{"issue":"6","key":"ref72","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/00002826-198812000-00004","article-title":"The nighttime problems of Parkinson's disease","volume":"11","author":"AJ Lees","year":"1988","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"ref73","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mds.1083","article-title":"Sudden daytime sleep onset in Parkinson's disease: polysomnographic recordings","volume":"16","author":"F Tracik","year":"2001","journal-title":"Mov Disord"},{"issue":"6","key":"ref74","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1365-2869.2012.01027.x","article-title":"Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?","volume":"21","author":"M Wienecke","year":"2012","journal-title":"Journal of sleep research"},{"issue":"11","key":"ref75","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s007020050228","article-title":"Nocturnal sleep structure and temperature slope in MPTP treated monkeys","volume":"106","author":"H Almirall","year":"1999","journal-title":"Journal of Neural Transmission"},{"issue":"2","key":"ref76","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.expneurol.2009.07.019","article-title":"Sleep disorders in Parkinson's disease: the contribution of the MPTP non-human primate model","volume":"219","author":"Q Barraud","year":"2009","journal-title":"Exp Neurol"},{"issue":"8","key":"ref77","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.5665\/SLEEP.1174","article-title":"REM sleep behavior disorder in the marmoset MPTP model of early Parkinson disease","volume":"34","author":"PS Verhave","year":"2011","journal-title":"Sleep"},{"issue":"27","key":"ref78","doi-asserted-by":"crossref","first-page":"9124","DOI":"10.1523\/JNEUROSCI.0181-14.2014","article-title":"Sleep Disorders in Parkinsonian Macaques: Effects of <span class = "sc">l<\/span>-Dopa Treatment and Pedunculopontine Nucleus Lesion","volume":"34","author":"H Belaid","year":"2014","journal-title":"The Journal of Neuroscience"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.nbd.2014.04.004","article-title":"Relationship between oscillatory activity in the cortico-basal ganglia network and parkinsonism in MPTP-treated monkeys","volume":"68","author":"A Devergnas","year":"2014","journal-title":"Neurobiol Dis"},{"issue":"2","key":"ref80","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1212\/WNL.46.2.388","article-title":"Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder","volume":"46","author":"CH Schenck","year":"1996","journal-title":"Neurology"},{"issue":"1","key":"ref81","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1007\/PL00007731","article-title":"Sleep disorders in Parkinson\u2019s disease","volume":"245","author":"F Stocchi","year":"1998","journal-title":"Journal of Neurology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0202770","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T10:54:21Z","timestamp":1720522461000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0202770"}},"subtitle":[],"editor":[{"given":"Joohyung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,8,23]]},"references-count":81,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0202770","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,23]]}}}